201 related articles for article (PubMed ID: 23529728)
1. Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.
Chamoun-Emanuelli AM; Pecheur EI; Simeon RL; Huang D; Cremer PS; Chen Z
Antimicrob Agents Chemother; 2013 Jun; 57(6):2571-81. PubMed ID: 23529728
[TBL] [Abstract][Full Text] [Related]
2. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T
Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503
[TBL] [Abstract][Full Text] [Related]
4. A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes.
Qian XJ; Zhang XL; Zhao P; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Zhu YZ; Qi ZT
Sci Rep; 2016 Jun; 6():27268. PubMed ID: 27252043
[TBL] [Abstract][Full Text] [Related]
5. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
[TBL] [Abstract][Full Text] [Related]
7. Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus.
Chamoun-Emanuelli AM; Pécheur EI; Chen Z
Antiviral Res; 2014 Sep; 109():141-8. PubMed ID: 25019406
[TBL] [Abstract][Full Text] [Related]
8. Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process.
Lv XQ; Zou LL; Tan JL; Li H; Li JR; Liu NN; Dong B; Song DQ; Peng ZG
Eur J Pharmacol; 2020 Sep; 883():173323. PubMed ID: 32622669
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro.
Hang X; Peng H; Song H; Qi Z; Miao X; Xu W
J Virol Methods; 2015 Sep; 222():150-7. PubMed ID: 26116793
[TBL] [Abstract][Full Text] [Related]
10. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain.
Chi X; Niu Y; Cheng M; Liu X; Feng Y; Zheng F; Fan J; Li X; Jin Q; Zhong J; Li YP; Yang W
Sci Rep; 2016 Apr; 6():25224. PubMed ID: 27121372
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and In Vitro anti-HCV and Antitumor Evaluation of Schisandronic Acid Derivatives.
Zhang KX; Qian XJ; Zheng W; Cai MC; Ma Y; Zhang DZ; Yu SC; Meng QG; Jin YS
Med Chem; 2021; 17(9):974-982. PubMed ID: 32819233
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
14. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
[TBL] [Abstract][Full Text] [Related]
15. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
Syder AJ; Lee H; Zeisel MB; Grove J; Soulier E; Macdonald J; Chow S; Chang J; Baumert TF; McKeating JA; McKelvy J; Wong-Staal F
J Hepatol; 2011 Jan; 54(1):48-55. PubMed ID: 20932595
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
17. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
[TBL] [Abstract][Full Text] [Related]
18. A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors.
Banda DH; Perin PM; Brown RJP; Todt D; Solodenko W; Hoffmeyer P; Kumar Sahu K; Houghton M; Meuleman P; Müller R; Kirschning A; Pietschmann T
J Hepatol; 2019 Jun; 70(6):1082-1092. PubMed ID: 30769006
[TBL] [Abstract][Full Text] [Related]
19. 5-Oxo-1-[(2,3,6,7-tetramethoxy-9-phenanthrenyl)methyl]-L-proline Inhibits Hepatitis C Virus Entry.
Nguyen LP; Park C; Luong TTD; Park EM; Choi DH; Han KM; Mai HN; Nguyen HC; Lim YS; Hwang SB
Sci Rep; 2019 May; 9(1):7288. PubMed ID: 31086268
[TBL] [Abstract][Full Text] [Related]
20. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]